SARS-CoV-2

Xiaofeng Li1, Liudmila Kulakova2, Kezzia Jones1

  • 1Abbratech Inc., 25 Business Park Drive, Suite C, Branford, CT 06405, USA.

New biotechnology
|December 21, 2023
PubMed
概括

埃皮沃尔夫技术精确地准SARS-CoV-2受体结合域上的特定位置,以产生中和抗体. 这种方法成功地产生了针对原始和Omicron菌株有效的泛变异抗体.